VAERS reports by lot

GSK Varicella/Shingles lot K2397: VAERS reports

26 VAERS reports list lot K2397 as a GSK Varicella/Shingles vaccine, received between 2019-11-08 and 2021-02-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
4%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2429%
Injection-site / Local reaction2429%
Dermatological (non-injection-site)1113%
Neurological78%
Musculoskeletal67%
Gastrointestinal56%
Cardiac / Cardiovascular22%
Allergic / Anaphylactic22%
Respiratory22%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Minnesota4
Iowa4
New York2
Pennsylvania2
South Dakota1
Georgia1
New Mexico1
Arizona1
Missouri1
Nevada1
Texas1

Reports by month received

2019-116
2019-1210
2020-011
2020-023
2020-032
2020-041
2020-051
2020-081
2021-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.